Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kark, J.
Right arrow Articles by Saikku, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kark, J.
Right arrow Articles by Saikku, P
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Vol 26, 730-738, Copyright © 1997 by International Epidemiological Association


ARTICLES

Chlamydia pneumoniae and acute myocardial infarction in Jerusalem

JD Kark, M Leinonen, O Paltiel and P Saikku
Epidemiology Unit, Hadassah Medical Organization, Jerusalem, Israel.

BACKGROUND: A number of studies in European and North American populations have reported associations between Chlamydia pneumoniae seropositivity and coronary heart disease (CHD). Our objective was to assess the association of IgG and IgA antibodies to C. pneumoniae with acute myocardial infarction (MI) in a population-based case-control study in a Middle Eastern country. METHODS: Eligible cases aged 25-64 with a first acute MI were ascertained through an active surveillance system in Jerusalem hospitals between 1987 and 1989 (85% response). Controls were Jerusalem residents aged 25-64 sampled from the national population registry (83% response). Data on sociodemographic variables, CHD history and risk factors were collected by interview. Chlamydia serology, available for 93% of eligible participants, was performed by microimmunofluorescence on frozen stored samples using the TWAR antigen. Altogether, 251 male and 51 female cases, and 324 male and 162 female controls were analysed. RESULTS: Overall, high IgG titres (> or = 128) were not associated with increased risk of acute MI (Odds ratio [OR] = 0.74 for men [95% confidence interval (CI): 0.47-1.17] and 0.91 for women [95% CI: 0.43-1.94]); neither were high IgA titres (> or = 80) (OR = 1.11 for men [95% CI: 0.71-1.73] and 1.15 for women [95% CI: 0.33-4.0]). At IgG and IgA titres of > 32 and > 20 respectively there was also no relation. CONCLUSIONS: An association of C. pneumoniae seropositivity with acute MI was not confirmed in this population with a very high IgG seropositivity prevalence of 84% in males and 69% in females. However, we cannot exclude the possibility that a postulated recent outbreak obscured an association with chronic C. pneumoniae infection.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
J. D Kark, N. A Kaufmann, F. Binka, N. Goldberger, and E. M Berry
Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids
Am. J. Clinical Nutrition, April 1, 2003; 77(4): 796 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Schumacher, A. B. Lerkerød, I. Seljeflot, L. Sommervoll, I. Holme, J. E. Otterstad, and H. Arnesen
Chlamydia pneumoniae Serology: Importance of Methodology in Patients with Coronary Heart Disease and Healthy Individuals
J. Clin. Microbiol., May 1, 2001; 39(5): 1859 - 1864.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Aalto-Setala, K. Laitinen, L. Erkkila, M. Leinonen, M. Jauhiainen, C. Ehnholm, M. Tamminen, M. Puolakkainen, I. Penttila, and P. Saikku
Chlamydia pneumoniae Does Not Increase Atherosclerosis in the Aortic Root of Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 578 - 584.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Ericson, T. G. P. Saldeen, O. Lindquist, C. Pahlson, and J. L. Mehta
Relationship of Chlamydia pneumoniae Infection to Severity of Human Coronary Atherosclerosis
Circulation, June 6, 2000; 101(22): 2568 - 2571.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Hoffmeister, D. Rothenbacher, P. Wanner, G. Bode, K. Persson, H. Brenner, V. Hombach, and W. Koenig
Seropositivity to chlamydial lipopolysaccharide and chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: Negative results of a case-control study
J. Am. Coll. Cardiol., January 1, 2000; 35(1): 112 - 118.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y.-k. Wong, K. D. Dawkins, and M. E. Ward
Circulating chlamydia pneumoniae DNA as a predictor of coronary artery disease
J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1435 - 1439.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
Y-K Wong, P J Gallagher, and M E Ward
Chlamydia pneumoniae and atherosclerosis
Heart, March 1, 1999; 81(3): 232 - 238.
[Abstract] [Full Text]


Home page
HeartHome page
L J Murray, D P J O'Reilly, G M L Ong, C O'Neill, A E Evans, and K B Bamford
Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile
Heart, March 1, 1999; 81(3): 239 - 244.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
Y.-k. Wong, M. Thomas, V. Tsang, P. J. Gallagher, and M. E. Ward
The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery
J. Am. Coll. Cardiol., January 1, 1999; 33(1): 152 - 156.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.